🇺🇸 L-Histidine in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 11

Most-reported reactions

1. Pruritus — 2 reports (18.18%)
2. Abdominal Pain Upper — 1 report (9.09%)
3. Affective Disorder — 1 report (9.09%)
4. Alopecia — 1 report (9.09%)
5. Asthma — 1 report (9.09%)
6. Chromaturia — 1 report (9.09%)
7. Depressed Mood — 1 report (9.09%)
8. Disturbance In Attention — 1 report (9.09%)
9. Dizziness — 1 report (9.09%)
10. Dysuria — 1 report (9.09%)

Source database →

Frequently asked questions

Is L-Histidine approved in United States?

L-Histidine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for L-Histidine in United States?

University of Miami is the originator. The local marketing authorisation holder may differ — check the official source linked above.